Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition

Abstract Tetrastatin, a 230 amino acid sequence from collagen IV, was previously demonstrated to inhibit melanoma progression. In the present paper, we identified the minimal active sequence (QKISRCQVCVKYS: QS-13) that reproduced the anti-tumor effects of whole Tetrastatin in vivo and in vitro on me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eléonore Lambert, Eloïse Fuselier, Laurent Ramont, Bertrand Brassart, Sylvain Dukic, Jean-Baptiste Oudart, Aurélie Dupont-Deshorgue, Christèle Sellier, Carine Machado, Manuel Dauchez, Jean-Claude Monboisse, François-Xavier Maquart, Stéphanie Baud, Sylvie Brassart-Pasco
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b13252cfd5e842f7aba5081827f0d566
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b13252cfd5e842f7aba5081827f0d566
record_format dspace
spelling oai:doaj.org-article:b13252cfd5e842f7aba5081827f0d5662021-12-02T15:09:12ZConformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition10.1038/s41598-018-28003-x2045-2322https://doaj.org/article/b13252cfd5e842f7aba5081827f0d5662018-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-28003-xhttps://doaj.org/toc/2045-2322Abstract Tetrastatin, a 230 amino acid sequence from collagen IV, was previously demonstrated to inhibit melanoma progression. In the present paper, we identified the minimal active sequence (QKISRCQVCVKYS: QS-13) that reproduced the anti-tumor effects of whole Tetrastatin in vivo and in vitro on melanoma cell proliferation, migration and invasion. We demonstrated that QS-13 binds to SK-MEL-28 melanoma cells through the αvβ3 integrin using blocking antibody and β3 integrin subunit siRNAs strategies. Relevant QS-13 conformations were extracted from molecular dynamics simulations and their interactions with αVβ3 integrin were analyzed by docking experiments to determine the binding areas and the QS-13 amino acids crucial for the binding. The in silico results were confirmed by in vitro experiments. Indeed, QS-13 binding to SK-MEL-28 was dependent on the presence of a disulfide-bound as shown by mass spectroscopy and the binding site on αVβ3 was located in close vicinity to the RGD binding site. QS-13 binding inhibits the FAK/PI3K/Akt pathway, a transduction pathway that is largely involved in tumor cell proliferation and migration. Taken together, our results demonstrate that the QS-13 peptide binds αvβ3 integrin in a conformation-dependent manner and is a potent antitumor agent that could target cancer cells through αVβ3.Eléonore LambertEloïse FuselierLaurent RamontBertrand BrassartSylvain DukicJean-Baptiste OudartAurélie Dupont-DeshorgueChristèle SellierCarine MachadoManuel DauchezJean-Claude MonboisseFrançois-Xavier MaquartStéphanie BaudSylvie Brassart-PascoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Eléonore Lambert
Eloïse Fuselier
Laurent Ramont
Bertrand Brassart
Sylvain Dukic
Jean-Baptiste Oudart
Aurélie Dupont-Deshorgue
Christèle Sellier
Carine Machado
Manuel Dauchez
Jean-Claude Monboisse
François-Xavier Maquart
Stéphanie Baud
Sylvie Brassart-Pasco
Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
description Abstract Tetrastatin, a 230 amino acid sequence from collagen IV, was previously demonstrated to inhibit melanoma progression. In the present paper, we identified the minimal active sequence (QKISRCQVCVKYS: QS-13) that reproduced the anti-tumor effects of whole Tetrastatin in vivo and in vitro on melanoma cell proliferation, migration and invasion. We demonstrated that QS-13 binds to SK-MEL-28 melanoma cells through the αvβ3 integrin using blocking antibody and β3 integrin subunit siRNAs strategies. Relevant QS-13 conformations were extracted from molecular dynamics simulations and their interactions with αVβ3 integrin were analyzed by docking experiments to determine the binding areas and the QS-13 amino acids crucial for the binding. The in silico results were confirmed by in vitro experiments. Indeed, QS-13 binding to SK-MEL-28 was dependent on the presence of a disulfide-bound as shown by mass spectroscopy and the binding site on αVβ3 was located in close vicinity to the RGD binding site. QS-13 binding inhibits the FAK/PI3K/Akt pathway, a transduction pathway that is largely involved in tumor cell proliferation and migration. Taken together, our results demonstrate that the QS-13 peptide binds αvβ3 integrin in a conformation-dependent manner and is a potent antitumor agent that could target cancer cells through αVβ3.
format article
author Eléonore Lambert
Eloïse Fuselier
Laurent Ramont
Bertrand Brassart
Sylvain Dukic
Jean-Baptiste Oudart
Aurélie Dupont-Deshorgue
Christèle Sellier
Carine Machado
Manuel Dauchez
Jean-Claude Monboisse
François-Xavier Maquart
Stéphanie Baud
Sylvie Brassart-Pasco
author_facet Eléonore Lambert
Eloïse Fuselier
Laurent Ramont
Bertrand Brassart
Sylvain Dukic
Jean-Baptiste Oudart
Aurélie Dupont-Deshorgue
Christèle Sellier
Carine Machado
Manuel Dauchez
Jean-Claude Monboisse
François-Xavier Maquart
Stéphanie Baud
Sylvie Brassart-Pasco
author_sort Eléonore Lambert
title Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
title_short Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
title_full Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
title_fullStr Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
title_full_unstemmed Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
title_sort conformation-dependent binding of a tetrastatin peptide to αvβ3 integrin decreases melanoma progression through fak/pi3k/akt pathway inhibition
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/b13252cfd5e842f7aba5081827f0d566
work_keys_str_mv AT eleonorelambert conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT eloisefuselier conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT laurentramont conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT bertrandbrassart conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT sylvaindukic conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT jeanbaptisteoudart conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT aureliedupontdeshorgue conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT christelesellier conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT carinemachado conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT manueldauchez conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT jeanclaudemonboisse conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT francoisxaviermaquart conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT stephaniebaud conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
AT sylviebrassartpasco conformationdependentbindingofatetrastatinpeptidetoavb3integrindecreasesmelanomaprogressionthroughfakpi3kaktpathwayinhibition
_version_ 1718387896184995840